Literature DB >> 6789357

Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.

L A Hershey, T Gift, R W Atkins, L Rivera-Calimlim.   

Abstract

Low chloropromazine (CPZ) levels have been measured in chronically treated schizophrenics. We tested six such patients to determine whether a 2-week CPZ-free period (drug holiday) would improve plasma CPZ levels. We also monitored psychiatric symptoms, autonomic function, and extrapyramidal signs. We found these patients to have low predose CPZ levels that did not change appreciably after the drug holiday. Peak levels following the holiday averaged 28 +/- 7 ng/ml higher than those measured prior to the holiday. Drug holidays are safe and should be examined more thoroughly as a means of improving plasma neuroleptic levels in chronically treated schizophrenics.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789357     DOI: 10.1007/BF00426465

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Chlorpromazine in the treatment of mental illness. II. Side effects and relapse rates.

Authors:  H C DENBER; E G BIRD
Journal:  Am J Psychiatry       Date:  1955-12       Impact factor: 18.112

2.  Medical effects of abrupt neuroleptic withdrawal.

Authors:  R B Lacoursiere; H E Spohn; K Thompson
Journal:  Compr Psychiatry       Date:  1976 Mar-Apr       Impact factor: 3.735

3.  Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector.

Authors:  S H Curry
Journal:  Anal Chem       Date:  1968-07       Impact factor: 6.986

4.  Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication.

Authors:  R F Prien; J O Cole; N F Belkin
Journal:  Br J Psychiatry       Date:  1969-06       Impact factor: 9.319

5.  Pharmacokinetics of chlorpromazine after single and chronic dosage.

Authors:  S G Dahl; R E Strandjord
Journal:  Clin Pharmacol Ther       Date:  1977-04       Impact factor: 6.875

6.  Low plasma levels of CPZ in patients chronically treated with neuroleptics.

Authors:  R J Wyatt; L Lasagna
Journal:  Commun Psychopharmacol       Date:  1978

7.  Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients.

Authors:  R C Smith; J Crayton; H Dekirmenjian; D Klass; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1979-05

8.  Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis.

Authors:  O T Phillipson; J M McKeown; J Baker; A F Healey
Journal:  Br J Psychiatry       Date:  1977-08       Impact factor: 9.319

9.  Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.

Authors:  B Wode-Helgodt; S Borg; B Fyrö; G Sedvall
Journal:  Acta Psychiatr Scand       Date:  1978-08       Impact factor: 6.392

10.  Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.

Authors:  L Rivera-Calimlim; H Nasrallah; J Strauss; L Lasagna
Journal:  Am J Psychiatry       Date:  1976-06       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.